Skip to main content
Drug Development
Our Pipeline
Evaluation Pipeline
Inaphaea BioLabs
Therapeutic areas
Partnering
Useful Links
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Shareholder communications
Investments Calculator
Share Alerts
Share Series
Share price look-up
Analyst Research
About us
Board of Directors and Management Team
Strategy and Vision
How we work
Working with us
Collaborative Pipeline
Contact us
Search
News
Breadcrumb
News
Category
Articles
Events and presentations
News
Press releases
Videos and audiocasts
Videos and audiocasts
Growth & Innovation Forum Presentation 2022
11 Feb 2022
Videos and audiocasts
ValiRx Signs Agreement with TheoremRX
5 Jan 2022
Videos and audiocasts
ValiRx Amends License for VAL201 with Cancer Research Technology
20 Dec 2021
Videos and audiocasts
ValiRx CEO, Dr Suzanne Dilly Presents at the LSE Investor Webinar
8 Dec 2021
Videos and audiocasts
Live Q&A Webinar With Presentation Held on 25th November 2021
26 Nov 2021
Events and presentations
Midweek Takeaway with ValiRx CEO Suzy Dilly - hosted by The Sunday Roast
4 Nov 2021
Events and presentations
ValiRx CEO Suzanne Dilly talks to BRR Media about today’s VAL201 announcement
2 Nov 2021
Events and presentations
ValiRx's Suzanne Dilly's Sunday Roast podcast with Zak Mir
18 Oct 2021
Articles
Life Science Innovation Article - Business & Industry UK
30 Sep 2021
Videos and audiocasts
Investor Update Presentation
29 Sep 2021
News
ValiRx 2020 Results Flash Note
4 May 2021
Videos and audiocasts
Extension of Collaboration Agreement
15 Feb 2021
Events and presentations
LSX Presentation: February 2021
1 Feb 2021
Videos and audiocasts
Our CEO discusses the VAL201 Clinical Trial results with BRR Media
30 Nov 2020
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Current page
3
Page
4
Next page
Next
Last page
Last
